Literature DB >> 15695837

The discovery of a multi-resistant Staphylococcus haemolyticus clone in the hospital and community environment in south western Nigeria.

Adebayo Osagie Shittu1, Johnson Lin, Donald Morrison, Deboye Oriade Kolawole.   

Abstract

Among clinically significant isolates of coagulase negative staphylococci, Staphylococcus haemolyticus is ranked second after Staphylococcus epidermidis. It has been associated with septicemia in newborns and various infections in persons with compromised host defenses and implanted foreign bodies. The existence of a multi-resistant Staphylococcus haemolyticus clone was discovered during a study on patients with skin and soft tissue infections at two local health clinics and in a referral hospital in South Western Nigeria. The clonal nature of these strains was determined by antibiotic susceptibility profile and pulsed field gel electrophoresis. This represents the first report of what appears to be a hospital-acquired and transmitted Staphylococcus haemolyticus clone in South Western Nigeria. Careful infection control measures and strain typing are urgently needed to understand species epidemiology and to limit the spread of multi-resistant strains within and beyond healthcare facilities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695837

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  2 in total

1.  Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria.

Authors:  Olugbenga Adekunle Olowe; Olayinka Oluwatoyin Kukoyi; Samuel Sunday Taiwo; Olusola Ojurongbe; Oluyinka Oladele Opaleye; Oloyede Samuel Bolaji; Abiodun Adebimpe Adegoke; Olufunmilola Bamidele Makanjuola; David Olusoga Ogbolu; Oyebode Terry Alli
Journal:  Infect Drug Resist       Date:  2013-08-20       Impact factor: 4.003

2.  Nasal colonization of methicillin resistant Staphylococcus aureus in Ethiopia: a systematic review and meta-analysis.

Authors:  Alemayehu Reta; Abeba Mengist; Asnakew Tesfahun
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-09-05       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.